Cardio Diagnostics Holdings, Inc.
CDIO
$0.4024
$0.00040.10%
| Weiss Ratings | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 4.32 | |||
| Price History | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -4.46% | |||
| 30-Day Total Return | -16.17% | |||
| 60-Day Total Return | -73.53% | |||
| 90-Day Total Return | 55.25% | |||
| Year to Date Total Return | -53.96% | |||
| 1-Year Total Return | -70.84% | |||
| 2-Year Total Return | -90.09% | |||
| 3-Year Total Return | -95.93% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -77.29% | |||
| 52-Week Low % Change | 111.58% | |||
| Price | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.77 | |||
| 52-Week Low Price | $0.19 | |||
| 52-Week Low Price (Date) | Oct 11, 2024 | |||
| 52-Week High Price (Date) | Dec 12, 2024 | |||
| Valuation | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.26M | |||
| Enterprise Value | 14.99M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.39 | |||
| Earnings Per Share Growth | -57.81% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 287.14 | |||
| Price/Book (Q) | 3.31 | |||
| Enterprise Value/Revenue (TTM) | 420.02 | |||
| Price | $0.40 | |||
| Enterprise Value/EBITDA (TTM) | -1.84 | |||
| Enterprise Value/EBIT | -1.79 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.44M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 302 281 2147 | |||
| Address | 311 West Superior Street Chicago, IL 60654 | |||
| Website | cardiodiagnosticsinc.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -23,505.60% | |||
| Profit Margin | -23,117.92% | |||
| Management Effectiveness | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -100.43% | |||
| Return on Equity | -- | |||
| Income Statement | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 35.70K | |||
| Total Revenue (TTM) | 35.70K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 35.70K | |||
| EBITDA (TTM) | -8.14M | |||
| EBIT (TTM) | -8.39M | |||
| Net Income (TTM) | -8.25M | |||
| Net Income Avl. to Common (TTM) | -8.25M | |||
| Total Revenue Growth (Q YOY) | -34.00% | |||
| Earnings Growth (Q YOY) | 26.90% | |||
| EPS Diluted (TTM) | -0.39 | |||
| EPS Diluted Growth (Q YOY) | 64.39% | |||
| Balance Sheet | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.98M | |||
| Cash Per Share (Q) | $0.08 | |||
| Total Current Assets (Q) | 2.63M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.69M | |||
| Current Ratio (Q) | 8.511 | |||
| Book Value Per Share (Q) | $0.12 | |||
| Total Assets (Q) | 4.48M | |||
| Total Current Liabilities (Q) | 308.70K | |||
| Total Debt (Q) | 720.50K | |||
| Total Liabilities (Q) | 795.30K | |||
| Total Common Equity (Q) | 3.69M | |||
| Cash Flow | CDIO - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -916.50K | |||
| Cash from Financing (TTM) | 4.56M | |||
| Net Change in Cash (TTM) | -1.65M | |||
| Levered Free Cash Flow (TTM) | -4.88M | |||
| Cash from Operations (TTM) | -5.29M | |||
